The National Comprehensive Cancer Network (NCCN) continues to build its NCCN Radiation Therapy Compendium with the publication of radiation therapy (RT) recommendations from an additional nine NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines):
Launched in March 2017, the NCCN Radiation Therapy Compendium now includes recommendations from 33 NCCN Guidelines. Additional cancer types will be published on a rolling basis over the coming months.
The NCCN Radiation Therapy Compendium provides guidance on all RT modalities recommended within the NCCN Guidelines, including intensity modulated radiation therapy (IMRT), intra-operative radiation therapy (IORT), stereotactic radiosurgery (SRS)/stereotactic body radiotherapy (SBRT)/stereotactic ablative radiotherapy (SABR), image-guided radiotherapy (IGRT), Low dose-rate brachytherapy (LDR)/high dose-rate brachytherapy (HDR), radioisotope, and particle therapy.
Transparency of NCCN Guidelines and Compendia development is central to the philosophy, policies, and procedures of NCCN. NCCN posts the policies and processes for developing and maintaining the NCCN Guidelines. These policies are available to the public on the NCCN website. Identification of newly published research, NCCN Member Institution review, external stakeholder submissions, and panel review occur on an ongoing basis with at least annual review performed for NCCN Guidelines for each disease.
The NCCN Guidelines are the recognized standard for clinical policy in cancer care and are the most thorough and most frequently updated clinical practice guidelines available in any area of medicine, according to an NCCN press release. Other derivative products of the NCCN Guidelines include:
For more information and to access the NCCN Radiation Therapy Compendium, visit NCCN.org/RTCompendium.Back To Top
Nine new disease sites added to the NCCN Radiation Therapy Compendium. Appl Rad Oncol.